Predictors of pneumonia severity in HIV-infected adults admitted to an urban public hospital

AIDS Patient Care and STDs

Volumn 25, Issue 5, 2011, Pages 273-277

  Chew, Kara W ^a   Yen, Irene H ^b   Li, Jonathan Z ^c   Winston, Lisa G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; COTRIMOXAZOLE; DAPSONE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; FEMALE; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OVERALL SURVIVAL; PNEUMONIA SEVERITY INDEX; PREDICTION; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; URBAN AREA;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HIV INFECTIONS; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS, PUBLIC; HOSPITALS, URBAN; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SAN FRANCISCO; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79955782891     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0365     Document Type: Article

References (25)

1. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995;333:845-851.
2. Madeddu G, Porqueddu EM, Cambosu F, et al. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection 2008;36:231-236.
3. Benito N, Rano A, Moreno A, et al. Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain. J Acquir Immune Defic Syndr 2001;27: 35-43. (Pubitemid 32587240)
4. Arozullah AM, Parada J, Bennett CL, et al. A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia. Chest 2003;123:1151-1160. (Pubitemid 36444373)
5. Curran A, Falco V, Crespo M, et al. Bacterial pneumonia in HIV-infected patients: Use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med 2008;9:609-615.
6. Malinis M, Myers J, Bordon J, et al. Clinical outcomes of HIV-infected patients hospitalized with bacterial community- acquired pneumonia. Int J Infect Dis 2010;14:e22-27.
7. Park DR, Sherbin VL, Goodman MS, et al. The etiology of community-acquired pneumonia at an urban public hospital: Influence of human immunodeficiency virus infection and initial severity of illness. J Infect Dis 2001;184: 268-277. (Pubitemid 32662172)
8. Grau I, Pallares R, Tubau F, et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005;165:1533-1540. (Pubitemid 41058035)
9. Boyton RJ. Infectious lung complications in patients with HIV/AIDS. Curr Opin Pulm Med 2005;11:203-207. (Pubitemid 40577169)
10. Feldman C. Pneumonia associated with HIV infection. Curr Opin Infect Dis 2005;18:165-170. (Pubitemid 40380217)
11. Heffernan RT, Barrett NL, Gallagher KM, et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 2005;191:2038-2045. (Pubitemid 40800574)
12. Jordano Q, Falco V, Almirante B, et al. Invasive pneumococcal disease in patients infected with HIV: Still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004;38:1623-1628. (Pubitemid 38738561)
13. Lopez-Palomo C, Martin-Zamorano M, Benitez E, et al. Pneumonia in HIV-infected patients in the HAART era: Incidence, risk, and impact of the pneumococcal vaccination. J Med Virol 2004;72:517-524. (Pubitemid 38296061)
14. Selik RM, Byers RH Jr, Dworkin MS. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002;29: 378-387. (Pubitemid 34288892)
15. Floris-Moore M, Lo Y, Klein RS, et al. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003;34:331-337. (Pubitemid 37377369)
16. Feldman C, Klugman KP, Yu VL, et al. Bacteraemic pneumococcal pneumonia: Impact of HIV on clinical presentation and outcome. J Infect 2007;55:125-135. (Pubitemid 47039053)
17. Johnson DH, Carriere KC, Houston S, et al. Hospitalization for community-acquired pneumonia in Alberta patients with human immunodeficiency virus infection: A case control study. Can Respir J 2003;10:265-270. (Pubitemid 37192988)
18. Touchie C, Marrie T. Comparison of community-acquired pneumonia requiring admission to hospital in HIV and non- HIV infected patients. Can J infect Dis 1996;7:253-258. (Pubitemid 26265888)
19. Mundy LM, Auwaerter PG, Oldach D, et al. Communityacquired pneumonia: Impact of immune status. Am J Respir Crit Care Med 1995;152(4 Pt 1):1309-1315.
20. Christensen D, Feldman C, Rossi P, et al. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: Results from the CAPO international cohort study. Clin Infect Dis 2005;41: 554-556. (Pubitemid 41099654)
21. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-250. (Pubitemid 27044625)
22. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-72. (Pubitemid 46290553)
23. Cordero E, Pachon J, Rivero A, et al. Community-acquired bacterial pneumonia in human immunodeficiency virusinfected patients: Validation of severity criteria. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Am J Respir Crit Care Med 2000;162:2063-2068. (Pubitemid 32051665)
24. Sanders KM,Marras TK, Chan CK. Pneumonia severity index in the immunocompromised. Can Respir J 2006;13:89-93.
25. Rizzi EB, Schinina V, Rovighi L, et al. HIV-related pneumococcal lung disease: Does highly active antiretroviral therapy or bacteremia modify radiologic appearance? AIDS Patient Care STDs 2008;22:105-111. (Pubitemid 351252583)